EILDX | VSGDX | EILDX / VSGDX | |
Total Expense Ratio | 1.15 | 0.10 | 1,150% |
Annual Report Gross Expense Ratio | 1.15 | 0.10 | 1,150% |
Fund Existence | 16 years | 24 years | - |
Gain YTD | 5.731 | 1.675 | 342% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.72B | 4.4B | 62% |
Annual Yield % from dividends | 5.75 | 3.64 | 158% |
Returns for 1 year | 6.11 | 0.88 | 694% |
Returns for 3 years | 11.29 | 0.24 | 4,642% |
Returns for 5 years | 10.75 | -6.04 | -178% |
Returns for 10 years | 21.86 | 0.99 | 2,207% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ENHNX | 10.36 | 0.01 | +0.10% |
Cullen Enhanced Equity Income I | |||
FBTTX | 26.30 | N/A | N/A |
Fidelity Advisor Biotechnology M | |||
PFISX | 12.00 | N/A | N/A |
Principal International Small Company R6 | |||
VVOSX | 22.74 | N/A | N/A |
Invesco Value Opportunities R6 | |||
SROAX | 13.30 | -0.10 | -0.75% |
Calamos Antetokounmpo Sustainable Eqs A |